Fish Oil Supplementation Enhances Pulmonary Strength and Endurance in Women Undergoing Chemotherapy

References

• National Institute of Cancer Brazil - INCA. Estimation 2016 of Cancer Incidence in Brazil. Available at: http://www.inca.gov.br/estimativa/2016/, accessed on 12/06/2016.
   Google Scholar
• Ismael GF, Rosa DD, Mano MS, and Awada A: Novel cytotoxic drugs: old challenges, new solutions. Cancer Treat Rev 34(1), 81–91, 2008.
   PubMed Web of Science ®Google Scholar
• Bougnoux P, Hajjaji N, Ferrassom MN, Giraudeau B, Couet C, et al.: Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial. Br J Cancer 101(12), 1978–1985, 2009.
   PubMed Web of Science ®Google Scholar
• Yerushalmi J, Kramer MR, Rizel S, Sulkes A, Gelmon K, et al.: Decline in pulmonary function in patients with breast cancer receiving dose dense chemotherapy: a prospective study. Ann Oncol 20(3), 437–440, 2009.
   PubMed Web of Science ®Google Scholar
• Ochoa R, Bejarano PA, Glück S, and Montero AJ: Pneumonitis and pulmonary fibrosis in a patient receiving adjuvant docetaxel and cyclophosphamide for stage 3 breast cancer: a case report and literature review. J Med Case Rep 30(6), 413, 2012.
   Google Scholar
• Prado CMM, Baracos VE, Bekaii-Saab TS, Doyle LA, Lieffers, JR, et al.: Muscle anabolism in advanced cancer: is cachexia an immutable phenomenon? J Clin Oncol 29(supl), e19623, 2011.
   Google Scholar
• Antoun S, Baracos VE, Birdsell L, Escudier B, and Sawyer MB: Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma. Ann Oncol 21(8), 1594–1598, 2010.
   PubMed Web of Science ®Google Scholar
• Pratt VC, Watanabe S, Bruera E, Mackey J, Clandidin MT, et al.: Plasma and neutrophil fatty acid composition in advanced cancer patients and response to fish oil supplementation. Br J Cancer 87(12), 1370–1378, 2002.
   PubMed Web of Science ®Google Scholar
• Zuijdgeest-Van Leeuwen SD, Van der Heijden MS, Rietveld T, Van den Berg JW, Tilanus H, et al.: Fatty acid composition of plasma lipids in patients with pancreatic, lung and esophageal cancer in comparison with healthy subjects. Clin Nutr 21(3), 225–230, 2002.
   PubMed Web of Science ®Google Scholar
• Murphy RA, Wilke MS, Perrine M, Pawlowicz M, Mourtzakis M, et al.: Loss of adipose tissue and plasma phospholipids: relationship to survival in advanced cancer patients. Clin Nutr 29(4), 482–487, 2010.
   PubMed Web of Science ®Google Scholar
• Murphy RA, Bureyko TF, Mourtzakis M, Chu QS, Clandinin MT, et al.: Aberrations in plasma phospholipid fatty acids in lung cancer patients. Lipids 47(4), 363–369, 2011.
   PubMed Web of Science ®Google Scholar
• Cvetkovic Z, Vucic V, Cvetkovic B, Petrovic M, Ristic-Medic D, et al.: Abnormal fatty acid distribution of the serum phospholipids of patients with non-Hodgkin lymphoma. Ann Hematol 89(8), 775–782, 2010.
   PubMed Web of Science ®Google Scholar
• Patterson RE, Flatt SW, Newman VA, Natarajan L, Rock CL, et al.: Marine fatty acid intake is associated with breast cancer prognosis. J Nutr 141(2), 201–206, 2011.
   PubMed Web of Science ®Google Scholar
• Read JA, Beale PJ, Volker DH, Smith N, Childs A, et al.: Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial. Support Care Cancer 15(3), 301–307, 2007.
   PubMed Web of Science ®Google Scholar
• Van der Meij BS, Langius JA, Spreeuwenberg MD, Slootmaker SM, Paul MA, et al.: Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT. Eur J Clin Nutr 66(3), 399–404, 2012.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society: Statement guidelines for the six-minute walk test. Am J Respir and Crit Care Med 166(1), 111–117, 2002.
   PubMed Web of Science ®Google Scholar
• Souza RB: Pressões respiratórias estáticas máximas. J Pneumol 28(3), S155–S165, 2002.
   Google Scholar
• Pereira CACI: Consenso Brasileiro de Espirometria. J Pneumol 22(3), 1–66, 1996.
   Google Scholar
• Donaldson MS: Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J 3, 19, 2004.
   PubMed Web of Science ®Google Scholar
• Menendez JA, Lupu R, and Colomer R: Exogenous supplementation with omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22:6n-3) synergistically enhances taxane cytotoxicity and downregulates Her-2/neu (c-erbB-2) oncogene expression in human breast cancer cells. Eur J Cancer Prev 14(3), 263–270, 2005.
   PubMed Web of Science ®Google Scholar
• Wang Z, Butt K, Wang L, and Liu H: The effect of seal oil on paclitaxel induced cytotoxicity and apoptosis in breast carcinoma MCF-7 and MDA-MB-231 cell lines. Nutr Cancer 58(2), 230–238, 2007.
   PubMed Web of Science ®Google Scholar
• Liu J and Ma DW: The role of n-3 polyunsaturated fatty acids in the prevention and treatment of breast cancer. Nutrients 6(11), 5184–5223, 2014.
   PubMed Web of Science ®Google Scholar
• Rose DP, Connolly JM, Rayburn J, and Coleman M: Influence of diets containing eicosapentaenoic or docosahexaenoic acid on growth and metastasis of breast cancer cells in nude mice. J Natl Cancer Inst 87(8), 587–592, 1995.
   PubMedGoogle Scholar
• Chiu LC and Wan JM: Induction of apoptosis in HL-60 cells by eicosapentaenoic acid (EPA) is associated with downregulation of bcl-2 expression. Cancer Lett 145(1–2), 17–27, 1999.
   PubMed Web of Science ®Google Scholar
• Barascu A, Besson P, Le Floch O, Bougnoux P, and Jourdan ML: CDK1-cyclin B1 mediates the inhibition of proliferation induced by omega-3 fatty acids in MDA-MB-231 breast cancer cells. Int J Biochem Cell Biol 38(2), 196–208, 2006.
   PubMed Web of Science ®Google Scholar
• Peoples GE and Mclennan PL: Long-chain n-3 DHA reduces the extent of skeletal muscle fatigue in the rat in vivo hindlimb model. Br J Nut 111(6), 996–1003, 2014.
   PubMed Web of Science ®Google Scholar
• Tartibian B, Maleki BH, and Abbasi A: The effects of omega-3 supplementation on pulmonary function of young wrestlers during intensive training. J Sc Med Sport 13(2), 281–286, 2010.
   PubMed Web of Science ®Google Scholar
• Rodacki CLN, Rodacki ALF, Pereira G, Naliwaiko K, Coelho I, et al.: Fish oil suplementation enhances the effect of strength training em elderly women. Am J Clin Nutr 95(2), 428–436, 2012.
   PubMed Web of Science ®Google Scholar
• Welch AA, Macgregor AJ, Minihane AM, Skinner J, Valdes AA, et al.: Dietary fat and fatty acid profile are associated with indices of skeletal muscle mass in women aged 18–79 years. J Nutr 144(3), 327–34, 2014.
   PubMed Web of Science ®Google Scholar
• Vincent F, Labourey JL, Leobon S, Antonini MT, Lavau-Denes S, et al.: Effects of a home-based walking training program on cardiorespiratory fitness in breast cancer patients receiving adjuvant chemotherapy: a pilot study. Eur J Phys Rehabil Med 49(3), 319–29, 2013.
   PubMed Web of Science ®Google Scholar
• Galanti G, Stefani L, and Gensini G: Exercise as a prescription therapy for breast and colon cancer survivors. Int J Gen Med 6, 245–51, 2013.
   PubMedGoogle Scholar
• Ehrmann-Jósko A, Siemińska J, Górnicka B, Ziarkiewicz-Wróblewska B, Ziółkowski B, et al.: Impaired glucose metabolism in colorectal cancer. Scand J Gastroenterol 41(9), 1079–86, 2006.
   PubMed Web of Science ®Google Scholar
• Farooki A and Schneider SH: Insulin resistance and cancer-related mortality. J Clin Oncol 25(12), 1628–1629, 2007.
   PubMed Web of Science ®Google Scholar
• Okuno M, Hamazaki K, Ogura T, Kitade H, Matsuura T, et al.: Abnormalities in fatty acids in plasma, erythrocytes and adipose tissue in Japanese patients with colorectal cancer. In Vivo 27(2), 203–10, 2013.
   PubMed Web of Science ®Google Scholar
• Bonatto SJR, Oliveira HHP, Nunes EA, Pequito D, Iagher F, et al.: Fish oil supplementation improves neutrophil function during cancer chemotherapy. Lipids 47, 383–389, 2012.
   PubMed Web of Science ®Google Scholar
• Kitahara CM, Berrington de González A, Freedman ND, Huxley R, Mok Y, et al.: Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol 29(12), 1592–1598, 2011.
   PubMed Web of Science ®Google Scholar
• Emaus A, Veierod MB, Tretli S, Finstad SE, Selmer R, et al.: Metabolic profile, physical activity, and mortality in breast cancer patients. Breast Cancer Res Treat 121(3), 651–660, 2010.
   PubMed Web of Science ®Google Scholar
• Tulinius H, Sigfusson N, Sigvaldason H, Bjarnadóttir K, and Tryggvadóttir L: Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev 6(11), 863–873, 1997.
   PubMed Web of Science ®Google Scholar
• Strohmaier S, Edlinger M, Manjer J, Stocks T, Bjorge T, et al.: Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can). PloS One 8(1), e54242, 2013.
   PubMed Web of Science ®Google Scholar
• Rodrigues Dos Santos C, Fonseca I, Dias S, and Mendes de Almeida JC: Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression. BMC Cancer 26(14), 132, 2014.
   Web of Science ®Google Scholar
• Robinson JG: Low high-density lipoprotein cholesterol and chronic disease risk marker or causal? J Am Coll Cardiol 55(25), 2855–2857, 2010.
   PubMed Web of Science ®Google Scholar
• Michalaki V, Koutroulis G, Syrigos K, Piperi C, and Kalofoutis A: Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer. Mol Cell Biochem 268(1–2), 19–24, 2005.
   PubMed Web of Science ®Google Scholar
• Kucharska-Newton AM, Rosamond WD, Mink PJ, Alberg AJ, Shahar E, et al.: HDL-cholesterol and incidence of breast cancer in the ARIC cohort study. Ann Epidemiol 18(9), 671–677, 2008.
   PubMed Web of Science ®Google Scholar
• Kim Y, Park SK, Han W, Kim DH, Hong YC, et al.: Serum high-density lipoprotein cholesterol and breast cancer risk by menopausal status, body mass index, and hormonal receptor in Korea. Canc Epidemiol Biomarkers Prev 18(2), 508–515, 2009.
   PubMed Web of Science ®Google Scholar
• Walenta S and Mueller-Klieser WF: Lactate: mirror and motor of tumor malignancy. Semin Radiat Oncol 14(3), 267–74, 2004.
   PubMed Web of Science ®Google Scholar
• Rofstad EK, Mathiesen B, Kindem K, and Galappathi K. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res 66(13), 6699–707, 2006.
   PubMed Web of Science ®Google Scholar
• Brizel DM, Schroeder T, Scher RL, Walenta S, Clough RW, et al.: Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys 51(2), 349–53, 2001.
   PubMed Web of Science ®Google Scholar